Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma

• Status: Completed
• Trial end date: 2023-04-30
• Target enrollment: 0
• Participant gender: All

Summary

ABSTRACT Objective: To study the efficacy while comparing Intralesional tranexamic acid Vs Platelets rich plasma (PRP) in treatment of Melasma.

Study design: Randomized-controlled trial (RCT). Study setting and duration: Dept of dermatology, CMH-Abbottabad, Nov-2022 /April-2023.

Methodology: The sample size of 60 patients 20 to 40 years were calculated by using Openepi App. The informed consent was taken. The patients were randomly allocated to two groups: Group A (30 patients injected with Intradermal Tranexamic acid (4mg/ml) and Group B (30 patients treated with PRP (1ml) intra-dermally, every fourth week for up to 12 weeks between both groups). The mMASI scale was used to evaluate all patients. The final evaluation was performed on the 24th week of follow-up. For analysis Statistical Package for the social sciences version-27 was used. To determine statistical significance a paired t-samples test with a p-value of < 0.05 was applied.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Combined Military Hospital Abbottabad
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• 20_40 years of age

• suffering from melasma

Exclusion Criteria:

• pregnancy

• breastfeeding mothers

• allergic to tranexamic acid

• bleeding disorders

• warts or facial eczema